Advances in revascularization for acute ischemic stroke treatment: An update

Expert Review of Neurotherapeutics

Volumn 11, Issue 8, 2011, Pages 1125-1139

  Eesa, Muneer ^a   Schumacher, Hermann Christian ^b   Higashida, Randall T ^c   Meyers, Philip M ^d  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b LEHIGH VALLEY HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

endovascular revascularization; endovascular treatment; ischemic stroke; thrombolysis

Indexed keywords

ABCIXIMAB; ALFIMEPRASE; ALTEPLASE; DESMOTEPLASE; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; OCRIPLASMIN; PLACEBO; RETEPLASE; TENECTEPLASE; TIROFIBAN; TISSUE PLASMINOGEN ACTIVATOR; TKNASE; UNCLASSIFIED DRUG; V 10153;

BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CATHETER; CLINICAL TRIAL; CONTINUOUS INFUSION; DEVICE; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG SAFETY; HEMODYNAMICS; HUMAN; MECHANICS; NEUROTOXICITY; PERCUTANEOUS THROMBECTOMY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RECANALIZATION; REVASCULARIZATION; REVIEW; STENT SUPPORTED THROMBECTOMY; STROKE; THROMBUS ASPIRATION;

CEREBRAL REVASCULARIZATION; FIBRINOLYTIC AGENTS; HUMANS; MECHANICAL THROMBOLYSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 79961099182     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.11.102     Document Type: Review

References (85)

1. The National Institute of Neurological Disorders rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N. Engl. J. Med. 333(24), 1581-1587 (1995).
2. Kwiatkowski TG, Libman RB, Frankel M et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N. Engl. J. Med. 340(23), 1781-1787 (1999).
3. Adams HP Jr, del Zoppo G, Alberts MJ et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 38(5), 1655-1711 (2007). (Pubitemid 46691097)
4. Brainin M, Olsen TS, Chamorro A et al. Organization of stroke care: education, referral, emergency management and imaging, stroke units and rehabilitation. European Stroke Initiative. Cerebrovasc. Dis. 17(Suppl. 2), 1-14 (2004). (Pubitemid 38067675)
5. Hacke W, Kaste M, Bluhmki E et al.; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med. 359(13), 1317-1329 (2008).
6. Ahmed N, Wahlgren N, Grond M et al.; SITS investigators. Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR. Lancet Neurol. 9(9), 866-874 (2010).
7. Morgenstern LB, Staub L, Chan W et al. Improving delivery of acute stroke therapy: the TLL Temple Foundation Stroke Project. Stroke 33(1), 160-166 (2002). (Pubitemid 34052204)
8. Wojner AW, Morgenstern L, Alexandrov AV, Rodriguez D, Persse D, Grotta JC. Paramedic and emergency department care of stroke: baseline data from a citywide performance improvement study. Am. J. Crit. Care 12(5), 411-417 (2003).
9. Hjort N, Butcher K, Davis SM et al. Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct. Stroke 36(2), 388-397 (2005). (Pubitemid 40170827)
10. Fiebach JB, Schellinger PD, Gass A et al. Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging. Stroke 35(2), 502-506 (2004). (Pubitemid 38174437)
11. Wintermark M, Reichhart M, Cuisenaire O et al. Comparison of admission perfusion computed tomography and qualitative diffusion- and perfusion-weighted magnetic resonance imaging in acute stroke patients. Stroke 33(8), 2025-2031 (2002). (Pubitemid 34840062)
12. Salomon EJ, Barfett J, Willems PW, Geibprasert S, Bacigaluppi S, Krings T. Dynamic CT angiography and CT perfusion employing a 320-detector row CT: protocol and current clinical applications. Klin. Neuroradiol. 19(3), 187-196 (2009).
13. Alexandrov AV, Molina CA, Grotta JC et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N. Engl. J. Med. 351(21), 2170-2178 (2004). (Pubitemid 39507629)
14. Saqqur M, Tsivgoulis G, Molina CA, Design of a PROspective multi-national CLOTBUST collaboration on reperfusion therapies for stroke (CLOTBUST-PRO).Int. J. Stroke 3(1), 66-72 (2008). (Pubitemid 351228148)
15. Kaur J, Zhao Z, Klein GM, Lo EH, Buchan AM. The neurotoxicity of tissue plasminogen activator? J. Cereb. Blood Flow Metab. 24(9), 945-963 (2004).
16. Liu D, Cheng T, Guo H et al. Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C. Nat. Med. 10(12), 1379-1383 (2004). (Pubitemid 40022721)
17. Schleuning WD. Vampire bat plasminogen activator DSPA-a-1 (desmoteplase): a thrombolytic drug optimized by natural selection. Haemostasis 31(3-6), 118-122 (2001).
18. Liberatore GT, Samson A, Bladin C, Schleuning WD, Medcalf RL. Vampire bat salivary plasminogen activator (desmoteplase): a unique fibrinolytic enzyme that does not promote neurodegeneration. Stroke 34(2), 537-543 (2003). (Pubitemid 36206361)
19. Hacke W, Albers G, Al-Rawi Y et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS).A Phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 36(1), 66-73 (2005). (Pubitemid 40054177)
20. Hacke W, Furlan AJ, Al-Rawi Y et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol. 8(2), 141-150 (2009).
21. Furlan AJ, Eyding D, Albers GW et al.; DEDAS Investigators. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 37(5), 1227-1231 (2006). (Pubitemid 43731867)
22. Verstraete M. Third-generation thrombolytic drugs. Am. J. Med. 109(1), 52-58 (2000). (Pubitemid 30608737)
23. Qureshi AI, Siddiqui AM, Kim SH et al. Reocclusion of recanalized arteries during intra-arterial thrombolysis for acute ischemic stroke. AJNR Am. J. Neuroradiol. 25(2), 322-328 (2004). (Pubitemid 38235318)
24. Alexandrov AV, Grotta JC. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology 59(6), 862-867 (2002).
25. Qureshi AI, Harris-Lane P, Kirmani JF et al. Intra-arterial reteplase and intravenous abciximab in patients with acute ischemic stroke: an open-label, dose-ranging, Phase I study. Neurosurgery 59(4), 789-796 (2006). (Pubitemid 44579600)
26. Schror K, Weber AA. Comparative pharmacology of GP IIb/IIIa antagonists. J. Thromb. Thrombolysis 15(2), 71-80 (2003). (Pubitemid 37498175)
27. The Abciximab in Ischemic Stroke Investigators. Abciximab in acute ischemic stroke: a randomized, double-blind, placebo-controlled, dose-escalation study. Stroke 31(3), 601-609 (2000).
28. Adams HP Jr, Effron MB, Torner J et al.; AbESTT-II Investigators. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international Phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II).Stroke 39(1), 87-99 (2008).
29. Seitz RJ, Hamzavi M, Junghans U, Ringleb PA, Schranz C, Siebler M. Thrombolysis with recombinant tissue plasminogen activator and tirofiban in stroke: preliminary observations. Stroke 34(8), 1932-1935 (2003). (Pubitemid 36944783)
30. Seitz RJ, Meisel S, Moll M, Wittsack HJ, Junghans U, Siebler M. The effect of combined thrombolysis with rtPA and tirofiban on ischemic brain lesions. Neurology 62(11), 2110-2112 (2004). (Pubitemid 38738234)
31. Straub S, Junghans U, Jovanovic V, Wittsack HJ, Seitz RJ, Siebler M. Systemic thrombolysis with recombinant tissue plasminogen activator and tirofiban in acute middle cerebral artery occlusion. Stroke 35(3), 705-709 (2004). (Pubitemid 38280845)
32. Furlan A, Higashida R, Wechsler L et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282(21), 2003-2011 (1999).
33. Alexandrov AV, Burgin WS, Demchuk AM, El-Mitwalli A, Grotta JC. Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: sonographic classification and short-term improvement. Circulation 103(24), 2897-2902 (2001). (Pubitemid 32578125)
34. Rother J, Schellinger PD, Gass A et al. Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke 33 10 2438-2445 2002
35. Nighoghossian N, Hermier M, Adeleine P et al. Baseline magnetic resonance imaging parameters and stroke outcome in patients treated by intravenous tissue plasminogen activator. Stroke 34(2), 458-463 (2003). (Pubitemid 36206348)
36. Alvarez-Sabin J, Molina CA, Ribo M et al. Impact of admission hyperglycemia on stroke outcome after thrombolysis: risk stratification in relation to time to reperfusion. Stroke 35(11), 2493-2498 (2004). (Pubitemid 39458405)
37. Alexandrov AV, Demchuk AM, Burgin WS, Robinson DJ, Grotta JC. Ultrasound-enhanced thrombolysis for acute ischemic stroke: Phase I. Findings of the CLOTBUST trial. J. Neuroimaging 14(2), 113-117 (2004). (Pubitemid 38391818)
38. Edwards MT, Murphy MM, Geraghty JJ, Wulf JA, Konzen JP. Intra-arterial cerebral thrombolysis for acute ischemic stroke in a community hospital. AJNR Am. J. Neuroradiol. 20(9), 1682-1687 (1999). (Pubitemid 29498622)
39. Jahan R, Duckwiler GR, Kidwell CS et al. Intraarterial thrombolysis for treatment of acute stroke: experience in 26 patients with long-term follow-up. AJNR Am. J. Neuroradiol. 20(7), 1291-1299 (1999). (Pubitemid 29400543)
40. Pillai JJ, Lanzieri CF, Trinidad SB, Tarr RW, Sunshine JL, Lewin JS. Initial angiographic appearance of intracranial vascular occlusions in acute stroke as a predictor of outcome of thrombolysis: initial experience. Radiology 218(3), 733-738 (2001). (Pubitemid 32172555)
41. Arnold M, Schroth G, Nedeltchev K et al. Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion. Stroke 33(7), 1828-1833 (2002). (Pubitemid 34761070)
42. Zaidat OO, Suarez JI, Santillan C et al. Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion. Stroke 33(7), 1821-1827 (2002).
43. Eckert B, Kucinski T, Pfeiffer G, Groden C, Zeumer H. Endovascular therapy of acute vertebrobasilar occlusion: early treatment onset as the most important factor. Cerebrovasc. Dis 14(1), 42-50 (2002). (Pubitemid 34827763)
44. Saqqur M, Uchino K, Demchuk AM et al. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 38(3), 948-954 (2007). (Pubitemid 46568457)
45. Heo JH, Lee KY, Kim SH, Kim DI. Immediate reocclusion following a successful thrombolysis in acute stroke: a pilot study. Neurology 60(10), 1684-1687 (2003). (Pubitemid 36618103)
46. Lewandowski CA, Frankel M, Tomsick TA et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 30(12), 2598-2605 (1999).
47. Ernst R, Pancioli A, Tomsick T et al. Combined intravenous and intra-arterial recombinant tissue plasminogen activator in acute ischemic stroke. Stroke 31(11), 2552-2557 (2000).
48. Hill MD, Barber PA, Demchuk AM et al. Acute intravenous-intra-arterial revascularization therapy for severe ischemic stroke. Stroke 33(1), 279-282 (2002). (Pubitemid 34052226)
49. Suarez JI, Zaidat OO, Sunshine JL, Tarr R, Selman WR, Landis DM. Endovascular administration after intravenous infusion of thrombolytic agents for the treatment of patients with acute ischemic strokes. Neurosurgery 50(2), 251-259 (2002). (Pubitemid 41672580)
50. IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 35(4), 904-911 (2004).
51. IMS II Trial Investigators. The Interventional Management of Stroke (IMS) II Study. Stroke 38, 2127-2135 (2007).
52. Khatri P, Hill MD, Palesch YY et al.; Interventional Management of Stroke III Investigators. Methodology of the Interventional Management of Stroke III Trial. Int. J. Stroke 3(2), 130-137 (2008). (Pubitemid 351566847)
53. Sorimachi T, Fujii Y, Tsuchiya N et al. Recanalization by mechanical embolus disruption during intra-arterial thrombolysis in the carotid territory. AJNR Am. J. Neuroradiol. 25(8), 1391-1402 (2004). (Pubitemid 44364351)
54. Mahon BR, Nesbit GM, Barnwell SL et al. North American Clinical Experience with the EKOS MicroLysUS Infusion Catheter for the Treatment of Embolic Stroke. AJNR Am. J. Neuroradiol. 24(3), 534-538 (2003). (Pubitemid 36359013)
55. Berlis A, Lutsep H, Barnwell S et al. Mechanical thrombolysis in acute ischemic stroke with endovascular photoacoustic recanalization. Stroke 35(5), 1112-1116 (2004). (Pubitemid 38543527)
56. Ringer AJ, Qureshi AI, Fessler RD, Guterman LR, Hopkins LN. Angioplasty of intracranial occlusion resistant to thrombolysis in acute ischemic stroke. Neurosurgery 48(6), 1282-1288 (2001).
57. Nakano S, Iseda T, Yoneyama T, Kawano H, Wakisaka S. Direct percutaneous transluminal angioplasty for acute middle cerebral artery trunk occlusion: an alternative option to intra-arterial thrombolysis. Stroke 33(12), 2872-2876 (2002). (Pubitemid 35462859)
58. Qureshi AI, Siddiqui AM, Suri MF et al. Aggressive mechanical clot disruption and low-dose intra-arterial third- generation thrombolytic agent for ischemic stroke: a prospective study. Neurosurgery 51(5), 1319-1329 (2002). (Pubitemid 36322720)
59. Song JK, Cacayorin ED, Campbell MS et al. Intracranial balloon angioplasty of acute terminal internal carotid artery occlusions. AJNR Am. J. Neuroradiol. 23(8), 1308-1312 (2002). (Pubitemid 35033878)
60. Yoneyama T, Nakano S, Kawano H et al. Combined direct percutaneous transluminal angioplasty and low-dose native tissue plasminogen activator therapy for acute embolic middle cerebral artery trunk occlusion. AJNR Am. J. Neuroradiol. 23(2), 277-281 (2002). (Pubitemid 34160435)
61. Agarwal P, Borden N, Tan WA, Sen S. Rescue angioplasty after failed intra-arterial thrombolysis in acute middle cerebral artery stroke: a case report. Catheter Cardiovasc. Interv. 62(3), 396-400 (2004). (Pubitemid 38868882)
62. Phatouros CC, Higashida RT, Malek AM et al. Endovascular stenting of an acutely thrombosed basilar artery: technical case report and review of the literature. Neurosurgery 44(3), 667-673 (1999). (Pubitemid 29098343)
63. SSYLVIA Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 35(6), 1388-1392 (2004).
64. Henkes H, Miloslavski E, Lowens S, Reinartz J, Liebig T, Kühne D. Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (WingSpan).Neuroradiology 47(3), 222-228 (2005). (Pubitemid 40778829)
65. Bose A, Hartmann M, Henkes H et al. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke 38(5), 1531-1537 (2007). (Pubitemid 46684170)
66. Levy EI, Mehta R, Gupta R et al. Self-expanding stents for recanalization of acute cerebrovascular occlusions. AJNR Am. J. Neuroradiol. 28(5), 816-822 (2007). (Pubitemid 46776054)
67. Kelly ME, Furlan AJ, Fiorella D. Recanalization of an acute middle cerebral artery occlusion using a self-expanding, reconstrainable, intracranial microstent as a temporary endovascular bypass. Stroke 39, 1770-1773 (2008).
68. Chopko BW, Kerber C, Wong W, Georgy B. Transcatheter snare removal of acute middle cerebral artery thromboembolism: technical case report. Neurosurgery 46(6), 1529-1531 (2000). (Pubitemid 32037687)
69. Kerber CW, Barr JD, Berger RM, Chopko BW. Snare retrieval of intracranial thrombus in patients with acute stroke. J. Vasc. Interv. Radiol. 13(12), 1269-1274 (2002). (Pubitemid 35440321)
70. Fourie P, Duncan IC. Microsnare-assisted mechanical removal of intraprocedural distal middle cerebral arterial thromboembolism. AJNR Am. J. Neuroradiol. 24(4), 630-632 (2003). (Pubitemid 36460730)
71. Schumacher HC, Meyers PM, Yavagal DR et al. Endovascular mechanical thrombectomy of an occluded superior division branch of the left MCA for acute cardioembolic stroke. Cardiovasc. Intervent. Radiol. 26(3), 305-308 (2003). (Pubitemid 37022425)
72. Nesbit GM, Luh G, Tien R, Barnwell SL. New and future endovascular treatment strategies for acute ischemic stroke. J. Vasc. Interv. Radiol. 15(1 Pt 2), S103-S110 (2004). (Pubitemid 38112677)
73. Mayer TE, Hamann GF, Brueckmann HJ. Treatment of basilar artery embolism with a mechanical extraction device: necessity of flow reversal. Stroke 33(9), 2232-2235 (2002). (Pubitemid 35014635)
74. Gobin PY, Starkman S, Duckwiler GR et al. MERCI 1. A Phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia. Stroke 35(12), 2848-2854 (2004).
75. Smith WS, Sung G, Starkman S et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 36, 1432-1438 (2005). (Pubitemid 40967507)
76. Smith WS, Sung G, Saver J et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 39(4), 1205-1212 (2008). (Pubitemid 351440692)
77. Roth C, Papanagiotou P, Behnke S et al. Stent-assisted mechanical recanalization for treatment of acute intracerebral artery occlusions. Stroke 41(11), 2559-2567 (2010).
78. Chapot R, Houdart E, Rogopoulos A, Mounayer C, Saint-Maurice JP, Merland JJ. Thromboaspiration in the basilar artery: report of two cases. AJNR Am. J. Neuroradiol. 23(2), 282-284 (2002). (Pubitemid 34160436)
79. Vallee JN, Crozier S, Guillevin R et al. Acute basilar artery occlusion treated by thromboaspiration in a cocaine and ecstasy abuser. Neurology 61(6), 839-841 (2003). (Pubitemid 37174487)
80. Lutsep HL, Clark WM, Nesbit GM, Kuether TA, Barnwell SL. Intraarterial suction thrombectomy in acute stroke. AJNR Am. J. Neuroradiol. 23(5), 783-786 (2002). (Pubitemid 34525692)
81. Bose A, Henkes H, Alfke K et al. The Penumbra System: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am. J. Neuroradiol. 29, 1409-1413 (2008).
82. Penumbra Pivotal Stroke Trial Investigators. The Penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 40(8), 2761-2768 (2009).
83. Bellon RJ, Putman CM, Budzik RF, Pergolizzi RS, Reinking GF, Norbash AM. Rheolytic thrombectomy of the occluded internal carotid artery in the setting of acute ischemic stroke. AJNR Am. J. Neuroradiol. 22(3), 526-530 (2001). (Pubitemid 32221422)
84. Higashida RT, Furlan AJ, Roberts H et al. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 34(8), e109-e137 (2003).
85. Schumacher HC, Gupta R, Higashida RT, Meyers PM. Advances in revascularization for acute ischemic stroke treatment. Expert Rev. Neurother. 5(2), 189-201 (2005). (Pubitemid 40445141)